Underfeeding-Induced Suppression of Mammary Tumors: Counteraction by Estrogen and Haloperidol

Abstract The purpose of this study was to investigate the mechanism by which underfeeding induces regression of carcinogen-induced mammary tumors in the rat and to determine if tumor regression in underfed rats could be prevented on a chronic basis by maintaining elevated circulating levels of estro...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Experimental biology and medicine (Maywood, N.J.) N.J.), 1993-06, Vol.203 (2), p.236-242
Hauptverfasser: Thyagarajan, S., Meites, J., Quadri, S. K.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 242
container_issue 2
container_start_page 236
container_title Experimental biology and medicine (Maywood, N.J.)
container_volume 203
creator Thyagarajan, S.
Meites, J.
Quadri, S. K.
description Abstract The purpose of this study was to investigate the mechanism by which underfeeding induces regression of carcinogen-induced mammary tumors in the rat and to determine if tumor regression in underfed rats could be prevented on a chronic basis by maintaining elevated circulating levels of estrogen and/or prolactin (PRL) by treatment with estradiol benzoate (EB) and a dopamine receptor blocker, haloperidol (HAL). Female rats with 7,12-dimethylbenzanthracene-induced mammary tumors were fed ad libitum (full-fed), half-fed (HF), or half-fed and treated with EB (HF+EB), HAL (HF+HAL), or both (HF+EB+HAL) for 15 weeks. Tumor diameter, tumor number, and body weight were determined each week. At the end of the experiment, hypothalamic concentrations of catecholamines, indoleamines, and their metabolites were determined by high performance liquid chromatography. Tumor diameter, tumor number, and body weight increased progressively in the full-fed rats, but decreased significantly in the HF rats. Treatment of HF rats with EB, HAL, or both prevented tumor regression, but had no effect on body weight, which declined continuously. In the HF rats, there was an increase in the concentration of dopamine and a decrease in the concentration of serotonin in the hypothalamus, whereas treatment with HAL reversed these effects. EB had no effect on neurotransmitter concentrations in the HF rats, but treatment of HF+EB animals with HAL decreased the dopamine concentration. The changes in dopamine and serotonin observed in HF rats are known to inhibit PRL secretion, whereas HAL, which blocked these changes, is a well established stimulator of PRL secretion. Since the mammary tumors are dependent on PRL for development and growth, it is probable that the regression of these tumors in the HF rats was ultimately due to a decrease in PRL secretion, and the prevention of this regression in HF+HAL rats was ultimately due to an increase in PRL secretion.
doi_str_mv 10.3181/00379727-203-43596
format Article
fullrecord <record><control><sourceid>sage_cross</sourceid><recordid>TN_cdi_pubmed_primary_7684845</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.3181_00379727-203-43596</sage_id><sourcerecordid>10.3181_00379727-203-43596</sourcerecordid><originalsourceid>FETCH-LOGICAL-c367t-b88fad010d92c190b02a704bb0b2eadca861cbfb17aab0ea49e2a740eaef9ae43</originalsourceid><addsrcrecordid>eNp9kD1PwzAQhi0EKqXwB5CQMrCa2vk2G6oKrVTEQDui6GxfqlSJHdnJwL8noaUjk0-65z3fPYTcc_YU8ZzPGYsykYUZDVlE4ygR6QWZ8iRKaJQKcUmmI0BH4prceH9gjCdZmE7IJEvzOI-TKfnaGY2uRNSV2dO10b1CHXz2bevQ-8qawJbBOzQNuO9g2zfW-edgYXvToQPVjYD8Dpa-c3aPJgCjgxXUtkVXaVvfkqsSao93p3dGdq_L7WJFNx9v68XLhqoozToq87wEzTjTIlRcMMlCyFgsJZMhglaQp1zJUvIMQDKEWOAAxEOFpQCMoxkJj3OVs947LIvWVePKBWfFqKr4U1UMqopfVUPo4Rhqe9mgPkdObob-46kPXkFdOjCq8mcszhMRpvmAzY-Yhz0WB9s7M5z638c_whaBEg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Underfeeding-Induced Suppression of Mammary Tumors: Counteraction by Estrogen and Haloperidol</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Thyagarajan, S. ; Meites, J. ; Quadri, S. K.</creator><creatorcontrib>Thyagarajan, S. ; Meites, J. ; Quadri, S. K.</creatorcontrib><description>Abstract The purpose of this study was to investigate the mechanism by which underfeeding induces regression of carcinogen-induced mammary tumors in the rat and to determine if tumor regression in underfed rats could be prevented on a chronic basis by maintaining elevated circulating levels of estrogen and/or prolactin (PRL) by treatment with estradiol benzoate (EB) and a dopamine receptor blocker, haloperidol (HAL). Female rats with 7,12-dimethylbenzanthracene-induced mammary tumors were fed ad libitum (full-fed), half-fed (HF), or half-fed and treated with EB (HF+EB), HAL (HF+HAL), or both (HF+EB+HAL) for 15 weeks. Tumor diameter, tumor number, and body weight were determined each week. At the end of the experiment, hypothalamic concentrations of catecholamines, indoleamines, and their metabolites were determined by high performance liquid chromatography. Tumor diameter, tumor number, and body weight increased progressively in the full-fed rats, but decreased significantly in the HF rats. Treatment of HF rats with EB, HAL, or both prevented tumor regression, but had no effect on body weight, which declined continuously. In the HF rats, there was an increase in the concentration of dopamine and a decrease in the concentration of serotonin in the hypothalamus, whereas treatment with HAL reversed these effects. EB had no effect on neurotransmitter concentrations in the HF rats, but treatment of HF+EB animals with HAL decreased the dopamine concentration. The changes in dopamine and serotonin observed in HF rats are known to inhibit PRL secretion, whereas HAL, which blocked these changes, is a well established stimulator of PRL secretion. Since the mammary tumors are dependent on PRL for development and growth, it is probable that the regression of these tumors in the HF rats was ultimately due to a decrease in PRL secretion, and the prevention of this regression in HF+HAL rats was ultimately due to an increase in PRL secretion.</description><identifier>ISSN: 0037-9727</identifier><identifier>ISSN: 1535-3702</identifier><identifier>EISSN: 1535-3699</identifier><identifier>EISSN: 1525-1373</identifier><identifier>DOI: 10.3181/00379727-203-43596</identifier><identifier>PMID: 7684845</identifier><identifier>CODEN: PSEBAA</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject>9,10-Dimethyl-1,2-benzanthracene ; Animals ; Biological and medical sciences ; Body Weight ; Dopamine - metabolism ; Estradiol - pharmacology ; Female ; Food Deprivation ; Gynecology. Andrology. Obstetrics ; Haloperidol - pharmacology ; Hydroxyindoleacetic Acid - metabolism ; Hypothalamus - drug effects ; Hypothalamus - metabolism ; Mammary gland diseases ; Mammary Neoplasms, Experimental - chemically induced ; Mammary Neoplasms, Experimental - pathology ; Mammary Neoplasms, Experimental - therapy ; Medical sciences ; Prolactin - metabolism ; Rats ; Rats, Sprague-Dawley ; Serotonin - metabolism ; Tumors</subject><ispartof>Experimental biology and medicine (Maywood, N.J.), 1993-06, Vol.203 (2), p.236-242</ispartof><rights>1993 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c367t-b88fad010d92c190b02a704bb0b2eadca861cbfb17aab0ea49e2a740eaef9ae43</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=4859268$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7684845$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Thyagarajan, S.</creatorcontrib><creatorcontrib>Meites, J.</creatorcontrib><creatorcontrib>Quadri, S. K.</creatorcontrib><title>Underfeeding-Induced Suppression of Mammary Tumors: Counteraction by Estrogen and Haloperidol</title><title>Experimental biology and medicine (Maywood, N.J.)</title><addtitle>Proc Soc Exp Biol Med</addtitle><description>Abstract The purpose of this study was to investigate the mechanism by which underfeeding induces regression of carcinogen-induced mammary tumors in the rat and to determine if tumor regression in underfed rats could be prevented on a chronic basis by maintaining elevated circulating levels of estrogen and/or prolactin (PRL) by treatment with estradiol benzoate (EB) and a dopamine receptor blocker, haloperidol (HAL). Female rats with 7,12-dimethylbenzanthracene-induced mammary tumors were fed ad libitum (full-fed), half-fed (HF), or half-fed and treated with EB (HF+EB), HAL (HF+HAL), or both (HF+EB+HAL) for 15 weeks. Tumor diameter, tumor number, and body weight were determined each week. At the end of the experiment, hypothalamic concentrations of catecholamines, indoleamines, and their metabolites were determined by high performance liquid chromatography. Tumor diameter, tumor number, and body weight increased progressively in the full-fed rats, but decreased significantly in the HF rats. Treatment of HF rats with EB, HAL, or both prevented tumor regression, but had no effect on body weight, which declined continuously. In the HF rats, there was an increase in the concentration of dopamine and a decrease in the concentration of serotonin in the hypothalamus, whereas treatment with HAL reversed these effects. EB had no effect on neurotransmitter concentrations in the HF rats, but treatment of HF+EB animals with HAL decreased the dopamine concentration. The changes in dopamine and serotonin observed in HF rats are known to inhibit PRL secretion, whereas HAL, which blocked these changes, is a well established stimulator of PRL secretion. Since the mammary tumors are dependent on PRL for development and growth, it is probable that the regression of these tumors in the HF rats was ultimately due to a decrease in PRL secretion, and the prevention of this regression in HF+HAL rats was ultimately due to an increase in PRL secretion.</description><subject>9,10-Dimethyl-1,2-benzanthracene</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Body Weight</subject><subject>Dopamine - metabolism</subject><subject>Estradiol - pharmacology</subject><subject>Female</subject><subject>Food Deprivation</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Haloperidol - pharmacology</subject><subject>Hydroxyindoleacetic Acid - metabolism</subject><subject>Hypothalamus - drug effects</subject><subject>Hypothalamus - metabolism</subject><subject>Mammary gland diseases</subject><subject>Mammary Neoplasms, Experimental - chemically induced</subject><subject>Mammary Neoplasms, Experimental - pathology</subject><subject>Mammary Neoplasms, Experimental - therapy</subject><subject>Medical sciences</subject><subject>Prolactin - metabolism</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Serotonin - metabolism</subject><subject>Tumors</subject><issn>0037-9727</issn><issn>1535-3702</issn><issn>1535-3699</issn><issn>1525-1373</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1993</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kD1PwzAQhi0EKqXwB5CQMrCa2vk2G6oKrVTEQDui6GxfqlSJHdnJwL8noaUjk0-65z3fPYTcc_YU8ZzPGYsykYUZDVlE4ygR6QWZ8iRKaJQKcUmmI0BH4prceH9gjCdZmE7IJEvzOI-TKfnaGY2uRNSV2dO10b1CHXz2bevQ-8qawJbBOzQNuO9g2zfW-edgYXvToQPVjYD8Dpa-c3aPJgCjgxXUtkVXaVvfkqsSao93p3dGdq_L7WJFNx9v68XLhqoozToq87wEzTjTIlRcMMlCyFgsJZMhglaQp1zJUvIMQDKEWOAAxEOFpQCMoxkJj3OVs947LIvWVePKBWfFqKr4U1UMqopfVUPo4Rhqe9mgPkdObob-46kPXkFdOjCq8mcszhMRpvmAzY-Yhz0WB9s7M5z638c_whaBEg</recordid><startdate>19930601</startdate><enddate>19930601</enddate><creator>Thyagarajan, S.</creator><creator>Meites, J.</creator><creator>Quadri, S. K.</creator><general>SAGE Publications</general><general>Blackwell Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>19930601</creationdate><title>Underfeeding-Induced Suppression of Mammary Tumors: Counteraction by Estrogen and Haloperidol</title><author>Thyagarajan, S. ; Meites, J. ; Quadri, S. K.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c367t-b88fad010d92c190b02a704bb0b2eadca861cbfb17aab0ea49e2a740eaef9ae43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1993</creationdate><topic>9,10-Dimethyl-1,2-benzanthracene</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Body Weight</topic><topic>Dopamine - metabolism</topic><topic>Estradiol - pharmacology</topic><topic>Female</topic><topic>Food Deprivation</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Haloperidol - pharmacology</topic><topic>Hydroxyindoleacetic Acid - metabolism</topic><topic>Hypothalamus - drug effects</topic><topic>Hypothalamus - metabolism</topic><topic>Mammary gland diseases</topic><topic>Mammary Neoplasms, Experimental - chemically induced</topic><topic>Mammary Neoplasms, Experimental - pathology</topic><topic>Mammary Neoplasms, Experimental - therapy</topic><topic>Medical sciences</topic><topic>Prolactin - metabolism</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Serotonin - metabolism</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Thyagarajan, S.</creatorcontrib><creatorcontrib>Meites, J.</creatorcontrib><creatorcontrib>Quadri, S. K.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Experimental biology and medicine (Maywood, N.J.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Thyagarajan, S.</au><au>Meites, J.</au><au>Quadri, S. K.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Underfeeding-Induced Suppression of Mammary Tumors: Counteraction by Estrogen and Haloperidol</atitle><jtitle>Experimental biology and medicine (Maywood, N.J.)</jtitle><addtitle>Proc Soc Exp Biol Med</addtitle><date>1993-06-01</date><risdate>1993</risdate><volume>203</volume><issue>2</issue><spage>236</spage><epage>242</epage><pages>236-242</pages><issn>0037-9727</issn><issn>1535-3702</issn><eissn>1535-3699</eissn><eissn>1525-1373</eissn><coden>PSEBAA</coden><abstract>Abstract The purpose of this study was to investigate the mechanism by which underfeeding induces regression of carcinogen-induced mammary tumors in the rat and to determine if tumor regression in underfed rats could be prevented on a chronic basis by maintaining elevated circulating levels of estrogen and/or prolactin (PRL) by treatment with estradiol benzoate (EB) and a dopamine receptor blocker, haloperidol (HAL). Female rats with 7,12-dimethylbenzanthracene-induced mammary tumors were fed ad libitum (full-fed), half-fed (HF), or half-fed and treated with EB (HF+EB), HAL (HF+HAL), or both (HF+EB+HAL) for 15 weeks. Tumor diameter, tumor number, and body weight were determined each week. At the end of the experiment, hypothalamic concentrations of catecholamines, indoleamines, and their metabolites were determined by high performance liquid chromatography. Tumor diameter, tumor number, and body weight increased progressively in the full-fed rats, but decreased significantly in the HF rats. Treatment of HF rats with EB, HAL, or both prevented tumor regression, but had no effect on body weight, which declined continuously. In the HF rats, there was an increase in the concentration of dopamine and a decrease in the concentration of serotonin in the hypothalamus, whereas treatment with HAL reversed these effects. EB had no effect on neurotransmitter concentrations in the HF rats, but treatment of HF+EB animals with HAL decreased the dopamine concentration. The changes in dopamine and serotonin observed in HF rats are known to inhibit PRL secretion, whereas HAL, which blocked these changes, is a well established stimulator of PRL secretion. Since the mammary tumors are dependent on PRL for development and growth, it is probable that the regression of these tumors in the HF rats was ultimately due to a decrease in PRL secretion, and the prevention of this regression in HF+HAL rats was ultimately due to an increase in PRL secretion.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><pmid>7684845</pmid><doi>10.3181/00379727-203-43596</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0037-9727
ispartof Experimental biology and medicine (Maywood, N.J.), 1993-06, Vol.203 (2), p.236-242
issn 0037-9727
1535-3702
1535-3699
1525-1373
language eng
recordid cdi_pubmed_primary_7684845
source MEDLINE; Alma/SFX Local Collection
subjects 9,10-Dimethyl-1,2-benzanthracene
Animals
Biological and medical sciences
Body Weight
Dopamine - metabolism
Estradiol - pharmacology
Female
Food Deprivation
Gynecology. Andrology. Obstetrics
Haloperidol - pharmacology
Hydroxyindoleacetic Acid - metabolism
Hypothalamus - drug effects
Hypothalamus - metabolism
Mammary gland diseases
Mammary Neoplasms, Experimental - chemically induced
Mammary Neoplasms, Experimental - pathology
Mammary Neoplasms, Experimental - therapy
Medical sciences
Prolactin - metabolism
Rats
Rats, Sprague-Dawley
Serotonin - metabolism
Tumors
title Underfeeding-Induced Suppression of Mammary Tumors: Counteraction by Estrogen and Haloperidol
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T08%3A06%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-sage_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Underfeeding-Induced%20Suppression%20of%20Mammary%20Tumors:%20Counteraction%20by%20Estrogen%20and%20Haloperidol&rft.jtitle=Experimental%20biology%20and%20medicine%20(Maywood,%20N.J.)&rft.au=Thyagarajan,%20S.&rft.date=1993-06-01&rft.volume=203&rft.issue=2&rft.spage=236&rft.epage=242&rft.pages=236-242&rft.issn=0037-9727&rft.eissn=1535-3699&rft.coden=PSEBAA&rft_id=info:doi/10.3181/00379727-203-43596&rft_dat=%3Csage_cross%3E10.3181_00379727-203-43596%3C/sage_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/7684845&rft_sage_id=10.3181_00379727-203-43596&rfr_iscdi=true